“The ‘A-‘ rating reflects our view of BMHC’s reduced operating losses, solid and competitive market share in a fairly large service area, strategic initiatives that could help increase revenue and further improve operations and acceptable pro forma unrestricted reserves,” said S&P analyst Suzie Desai.
The outlook is negative, reflecting S&P’s view of BMHC’s continued operating losses through interim 2016 that aren’t indicative of a credit in the “A” category.
More articles on healthcare finance:
5 study findings on health spending related to opioid addiction treatment
Cayman hospital system OKs large debt write-off
UnitedHealth’s Optum takes over Quest Diagnostics’ billing processes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
